Global In-vitro Diagnostics Enzymes Market Size & Outlook

The in-vitro diagnostics enzymes industry worldwide is expected to reach a projected revenue of US$ 3,699.7 million by 2030. A compound annual growth rate of 7.9% is expected of the worldwide in-vitro diagnostics enzymes industry from 2024 to 2030.
Revenue, 2023 (US$M)
$2,179.8
Forecast, 2030 (US$M)
$3,699.7
CAGR, 2024 - 2030
7.9%
Report Coverage
Worldwide

Global in-vitro diagnostics enzymes market, 2018-2030 (US$M)

Global in-vitro diagnostics enzymes market highlights

  • The global in-vitro diagnostics enzymes market generated a revenue of USD 2,179.8 million in 2023 and is expected to reach USD 3,699.7 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 7.9% by 2030.
  • In terms of segment, proteases accounted for a revenue of USD 2,179.8 million in 2023.
  • Proteases is the most lucrative enzyme type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.

Global data book summary

Market revenue in 2023USD 2,179.8 million
Market revenue in 2030USD 3,699.7 million
Growth rate7.9% (CAGR from 2023 to 2030)
Largest segmentProteases
Fastest growing segmentProteases
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProteases

Other key industry trends

  • In terms of revenue, the North America accounted for 41.7% of the global in-vitro diagnostics enzymes market in 2023.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In-vitro Diagnostics Enzymes Market Scope

In-vitro diagnostics enzymes market segmentation & scope
Infectious disease
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune diseases
Others
Technology Use
Histology Assays
Molecular Diagnostics
PCR Assays
NGS Assays
Others
Clinical Chemistry
Physical Form
Powder
Liquid
Type
Natural
Recombinant
End Use
Pharma & Biotech
Hospital & Diagnostic Labs
CROs
Academic Labs
Polymerase & Transcriptase
Ribonuclease
Others
Therapeutic Area
Infectious disease
COVID-19 Testing
Hepatitis
HIV
Others
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune diseases
Others
Technology Type
Histology Assays
Molecular Diagnostics
PCR Assays
NGS Assays
Others
Clinical Chemistry
End Use
Pharma & Biotech
Hospital & Diagnostic Labs
CROs
Academic Labs
Countries
Argentina
Brazil
Mexico
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
U.S.
Canada
UAE
South Africa
Saudi Arabia
Kuwait
Thailand
South Korea
India
China
Japan
Australia

In-vitro Diagnostics Enzymes Market Companies

Name Profile # Employees HQ Website

Global in-vitro diagnostics enzymes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.


Proteases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global In-vitro Diagnostics Enzymes Enzyme Type Outlook (Revenue, USD Million, 2018-2030)
    • Proteases
      • Therapeutic Area
        • Infectious disease
        • Diabetes
        • Oncology
        • Cardiology
        • Nephrology
        • Autoimmune diseases
        • Others
      • Technology Use
        • Histology Assays
        • Molecular Diagnostics
          • PCR Assays
          • NGS Assays
          • Others
        • Clinical Chemistry
      • Physical Form
        • Powder
        • Liquid
      • Type
        • Natural
        • Recombinant
      • End Use
        • Pharma & Biotech
        • Hospital & Diagnostic Labs
        • CROs
        • Academic Labs
    • Polymerase & Transcriptase
    • Ribonuclease
    • Others
  • Global In-vitro Diagnostics Enzymes Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
    • Infectious disease
      • COVID-19 Testing
      • Hepatitis
      • HIV
      • Others
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune diseases
    • Others
  • Global In-vitro Diagnostics Enzymes Technology Type Outlook (Revenue, USD Million, 2018-2030)
    • Histology Assays
    • Molecular Diagnostics
      • PCR Assays
      • NGS Assays
      • Others
    • Clinical Chemistry
  • Global In-vitro Diagnostics Enzymes End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharma & Biotech
    • Hospital & Diagnostic Labs
    • CROs
    • Academic Labs

Reasons to subscribe to Global in-vitro diagnostics enzymes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global in-vitro diagnostics enzymes market databook

  • Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global in-vitro diagnostics enzymes market, including forecasts for subscribers. This global databook contains high-level insights into Global in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global in vitro diagnostics enzymes market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more